Cardiogenesis Corporation - Cardiogenesis Transmyocardial Laser. The device is indicated for use in the treatment of patients with angina (Canadian Cardiovascular Society Class 4) refractory to medical treatment and secondary to objectively demonstrated coronary artery atherosclerosis and with a region of the myocardium with reversible ischemia not amenable to direct coronary revascularization.
Published September 18, 2013 · Recall initiated: May 1, 2011
Summary
FDA records medical device Class II recall Z-1993-2013, published September 18, 2013 and initiated May 1, 2011. Recalling firm: Cardiogenesis Corporation; Status: Terminated; Reported quantity: 2498; Lot: Product Code - HP-SG3 Product Code -HP-PRL5. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Following acquisition of Cardiogenesis, we began receiving complaints of sparks, burns, or smoke incidents related to the handpieces.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cardiogenesis Corporation
- Distributor
- US Distribution
- Lot
- Product Code - HP-SG3 Product Code -HP-PRL5
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDANew Sun Immune 101, Dietary Supplement 360 Capsule bottles and 100 capsule bottles, New Sun, Inc,September 18, 2013
- FDAMicroscan Synergies Plus Negative Urine Combo 1 Product Usage: MicroScan® Synergies plus® Panels &September 18, 2013
- FDANew Sun JLB Combination, Dietary Supplement, 100 capsule bottle, New Sun, Inc., Hendersonville, NCSeptember 18, 2013
- FDAMicroscan Synergies Plus Negative Combo 2 Product Usage: MicroScan® Synergies plus® Panels & MicroScan®September 18, 2013
- FDAClinical LIVE Dietary Supplement Immune Support 694.325 mg 90 capsules Distributed by Reaction Nutrition,September 18, 2013
- FDAMicroscan Synergies Plus Negative Breakpoint Combo 7 Product Usage: MicroScan® Synergies plus® Panels &September 18, 2013
Questions about this recall
Was Cardiogenesis Corporation - Cardiogenesis Transmyocardial Laser. The device is indicated for use in the treatment of patients with angina (Canadian Cardiovascular Society Class 4) refractory to medical treatment and secondary to objectively demonstrated coronary artery atherosclerosis and with a region of the myocardium with reversible ischemia not amenable to direct coronary revascularization. recalled?
Yes. FDA published recall Z-1993-2013 on September 18, 2013. Reported hazard: Following acquisition of Cardiogenesis, we began receiving complaints of sparks, burns, or smoke incidents related to the handpieces.
What should I do if I have this product?
Voluntary: Firm initiated · Letter